Physician profile
Tri Le
NPI 1053671743
$1,720.91
in general payments reported to CMS, 2019-2025
12 companies · $818 in 2025
The $818 reported for 2025 was more than what 82% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $12.71 · 2022: $403 · 2023: $25.05 · 2024: $463 · 2025: $818.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,305.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,305.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $758.17 | 2022-2025 | Affinity, Apligraf, Nushield |
| Kerecis Limited | $275.58 | 2024-2025 | Kerecis Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Medtronic, INC. | $145.59 | 2025 | Hawkone, Abre |
| Urgo Medical North America, LLC | $132.81 | 2024-2025 | Urgoclean Ag |
| Smith+Nephew, INC. | $117.05 | 2019-2025 | Renasys Touch, Grafix, Grafix Pl |
| Medline Industries LP | $79.52 | 2025 | |
| Acera Surgical, INC. | $51.50 | 2022 | |
| Reprise Biomedical, INC. | $43.09 | 2025 | Miro3d |
| Solventum Corporation | $38.50 | 2024-2025 | Activ.A.C., Promogran Prisma, Kerramax Care |
| Molnlycke Health Care US, LLC | $32.22 | 2022-2023 | Mepilex Border Flex, Exufiber Ag+, Mepilex Border Post-Op |
| Kci USA, INC. | $29.22 | 2022-2023 | Activ.A.C., Promogran Prisma |
| Mimedx Group, INC. | $17.66 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tri Le listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.